{"id":47731,"date":"2022-08-29T10:02:37","date_gmt":"2022-08-29T08:02:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/"},"modified":"2022-08-29T10:02:37","modified_gmt":"2022-08-29T08:02:37","slug":"horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/","title":{"rendered":"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced it submitted a planning application to expand its development and manufacturing facility in Waterford, Ireland to add new drug substance biologics development and manufacturing capabilities. The planned facility would expand Horizon\u2019s footprint, adding approximately 320,000 square feet to its current 44,000 square foot drug product (fill-finish) biologics facility, and would create approximately 350 jobs over time. Horizon anticipates providing additional details with respect to potential investment and timeline as the planning application process proceeds.\n<\/p>\n

<\/a><\/p>\n

\nHorizon purchased its existing facility in June 2021 for $65 million with the understanding that adjacent Industrial Development Agency (IDA) Ireland land was available for further manufacturing and development expansion. Horizon continues to work with Ireland\u2019s Health Products Regulatory Authority (HPRA) and the U.S. Food and Drug Administration (FDA) to obtain HPRA and FDA licensure for sterile fill-finish manufacturing and anticipates the first medicine approved for release from the existing facility in 2023. Both facilities are expected to be used for Horizon\u2019s on market rare disease biologics as well as development-stage medicines.\n<\/p>\n

\n\u201cAs we grow as a global biotechnology company, it is important to continue to invest in our development and manufacturing capabilities to supplement our current network of contract manufacturing organizations to maintain flexibility over our production and supply,\u201d said Tim Walbert, chairman, president and chief executive officer, Horizon. \u201cThe planned expansion to add this drug substance facility is important to the long-term growth of our commercial and pipeline biologics as well as our commitment to Ireland.\u201d\n<\/p>\n

\nAbout Horizon<\/b>\n<\/p>\n

\nHorizon is a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: We apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, visit www.horizontherapeutics.com<\/a> and follow us on Twitter<\/a>, LinkedIn<\/a>, Instagram<\/a> and Facebook<\/a>.\n<\/p>\n

\nForward Looking Statements<\/b>\n<\/p>\n

\nThis press release contains forward-looking statements, including, but not limited to, statements related to the potential expansion of Horizon\u2019s manufacturing facility, Horizon\u2019s expected use of the facility, timelines for regulatory approvals and release of medicine from Horizon\u2019s existing facility, and expectations regarding job creation as a result of the expanded facility. These forward-looking statements are based on Horizon\u2019s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with the planning application and regulatory approval processes, changes in circumstances that could cause Horizon to modify its plans or actual uses of the facility, potential delays in the planning application, construction, validation or regulatory approval processes, and those risks detailed from time-to-time under the caption \u201cRisk Factors\u201d and elsewhere in Horizon\u2019s filings and reports with the SEC. Horizon undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nTina Ventura<\/b>
Senior Vice President, Chief Investor Relations Officer
\n
Investor-relations@horizontherapeutics.com<\/a>\n<\/p>\n

\nU.S. Media:<\/b>
Geoff Curtis<\/b>
Executive Vice President, Corporate Affairs & Chief Communications Officer
\n
media@horizontherapeutics.com<\/a>\n<\/p>\n

\nIreland Media:<\/b>
Gordon MRM<\/b>
Ray Gordon
\n
ray@gordonmrm.ie<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced it submitted a planning application to expand its development and manufacturing facility in Waterford, Ireland to add new drug substance biologics development and manufacturing capabilities. The planned facility would expand Horizon\u2019s footprint, adding approximately 320,000 square feet to its current 44,000 square foot drug product (fill-finish) biologics … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47731","6":"format-standard","7":"category-industry"},"yoast_head":"\nHorizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced it submitted a planning application to expand its development and manufacturing facility in Waterford, Ireland to add new drug substance biologics development and manufacturing capabilities. The planned facility would expand Horizon\u2019s footprint, adding approximately 320,000 square feet to its current 44,000 square foot drug product (fill-finish) biologics ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-29T08:02:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220828005031\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland\",\"datePublished\":\"2022-08-29T08:02:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/\"},\"wordCount\":577,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220828005031\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/\",\"name\":\"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220828005031\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\",\"datePublished\":\"2022-08-29T08:02:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220828005031\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220828005031\\\/en\\\/1460023\\\/21\\\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/","og_locale":"en_US","og_type":"article","og_title":"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland - Pharma Trend","og_description":"DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced it submitted a planning application to expand its development and manufacturing facility in Waterford, Ireland to add new drug substance biologics development and manufacturing capabilities. The planned facility would expand Horizon\u2019s footprint, adding approximately 320,000 square feet to its current 44,000 square foot drug product (fill-finish) biologics ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-29T08:02:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220828005031\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland","datePublished":"2022-08-29T08:02:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/"},"wordCount":577,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220828005031\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/","url":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/","name":"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220828005031\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","datePublished":"2022-08-29T08:02:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220828005031\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220828005031\/en\/1460023\/21\/Horizon_Logo_Full-Color_RGB_Registered_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/horizon-therapeutics-plc-announces-plans-to-expand-its-development-and-manufacturing-facility-in-waterford-ireland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47731"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47731\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47731"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}